Immunovant
IMVT
IMVT
87 hedge funds and large institutions have $696M invested in Immunovant in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
+47
Holders Change %
+117.5%
% of All Funds
1.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
47
Increased
29
Reduced
11
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$41.2M |
| 2 |
BlackRock
New York
|
$56.1M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
$57.6M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
$43.1M |
| 5 |
RI
RTW Investments
New York
|
$139M |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
$6.87M |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
$3.17M |
| 3 |
GTC
Ghost Tree Capital
New York
|
$12.8M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
$5.62M |
| 5 |
BFM
Boothbay Fund Management
New York
|
$865K |
